Izenbio - Due diligence report

A 360° intelligence report on Izenbio: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

2011-04-21 Secunderabad, Telangana Active Unlisted Active Non-Compliant
Share
Connect MCP
IZ Izenbio
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Izenbio — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Izenbio is assessed as Moderate with a Trust Score of 62/100. Izenbio is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 02 Oct 2026 from the latest processed filings. Izen Biosciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
18/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 2 satisfied (7.24 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Dena Bank1 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 18/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: MCA.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
DR RER NAT BOS MICHAEL 01234567 Director 01/04/2018 6 yrs Approved
JOHN REJI MALAYIL KUCHENTUNGU 01234567 Director 01/04/2018 6 yrs Approved
SREE RAMA RATAN VOLETY 01234567 Director 01/04/2018 6 yrs Approved
RAMKUMAR SARMA VISHNUBHOTLA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • DR RER NAT BOS MICHAEL has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2015)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 15+ years.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (18/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence50/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view47/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
16 Mar 2019
Charge satisfied
Dena Bank
01 Nov 2018
Director appointed
RAMKUMAR SARMA VISHNUBHOTLA (Director)
05 Apr 2018
Director ceased
NARENDRA MALLAKUNTA
18 Dec 2017
Director ceased
RAMKUMAR SARMA VISHNUBHOTLA
07 Nov 2017
Director appointed
SREE RAMA RATAN VOLETY (Director)
26 Oct 2017
Director ceased
VASUDEV KOMARAJU
05 Sep 2017
Director ceased
HARSHAL SUBHASH VIBHANDIK
17 Jan 2017
Director ceased
JANAKI RAM AJJARAPU
18 Aug 2016
Director ceased
JOHN REJI MALAYIL KUCHENTUNGU
26 Jun 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
27 Mar 2014
Securities allotted
2900000.00 Equity Shares - 29.00 Lakh raised
26 Mar 2014
Securities allotted
5665430.00 Equity Shares - 56.65 Lakh raised
20 Mar 2013
Securities allotted
2000000.00 Equity Shares - 30.00 Lakh raised
18 Jan 2013
Charge satisfied
State Bank Of India
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2015 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Chemical Udyog Private Limited U24100OR2012PTC015251 Rourkela, Orissa, India
Satrite Manusec Private Limited U24129PN1989PTC182664 Pune, Maharashtra, India
Appli Coat Services Private Limited U74900DL2009PTC190056 Rohini, Delhi, India
Quester Capsules Private Limited U33111MH2011PTC214098 Nashik, Maharashtra, India
Candor Biotech Limited U24232CH2002PLC025265 U T, Chandigarh, India
Natcopharma U24231TN1994PLC027491 Chennai, Tamil Nadu, India
Sapphire Polyvinyl Private Limited U24134DL2012PTC233964 New Delhi, Delhi, India
Biotropics Pharma Private Limited U74899DL2001PTC109299 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Izenbio before audits and certifications: compliance score 18/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Izenbio: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Izenbio - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Izenbio pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Izenbio - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Izenbio an active company?

Izenbio has MCA status “Active” with a compliance score of 18/100 (Caution Indicated).

Is Izenbio financially healthy?

Izenbio has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Izenbio?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Izenbio?

Promoters hold a minority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Izenbio have loans or charges against its assets?

No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Izenbio up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 18/100 (Caution Indicated).

Is it risky to lend to Izenbio?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.